INTRODUCTION
Benzimidazole and its derivatives are interesting heterocycles because of their presence in many various medicaments. It has been found that they possess antibacterial, antifungal, antihistaminic, cytostatic, local analgesic, hypotensive and antiinflammatory activity (1) (2) (3) (4) (5) (6) . It was confirmed to have a moderate in vitro anti-HIV activity (7, 8) . In recent years, transition metal complexes have attracted particular interest because of their potenDr. Sanja O. Podunavac-Kuzmanović, Assist. Prof., Dragoljub Cvetković, М.Sc., Assist., 1 Dr. Gordana S. Ćetko-vić, Assist. Prof., Faculty of Technology, 21000 Novi Sad, Bul. Cara Lazara 1, Serbia and Montenegro potential use in several homogeneously catalyzed processes, such as hydrogenation, hydroformylation and acetylation reactions. However, in the recent time, possible therapeutic properties of the metal complexes have been examined. It was found that the complexes of transition metals with benzimidazole derivatives showed a higher antimicrobial activitiy than the corresponding ligands (9) (10) (11) (12) (13) .
Following our studies of the reactivity of benzimidazole derivatives with metallic halides (10-13), we evaluated the antimicrobial activity of this type of complexes in this study. We report in vitro antimicrobial activities of 2-amino benzimidazoles and their cobalt(II) complexes against three gram-positive bacterial strains: Bacillus sp., Staphylococcus aureus and Sarcina lutea, one gram-negative isolate: Pseudomonas aeruginosa and yeast, Saccharomyces cerevisiae.
EXPERIMENTAL

Reagents
All chemicals used to prepare the ligands and complexes were of analytical reagent grade, commercially available from different sources. The ligands were synthesized as described in the literature (14) . 
Synthesis of complexes
Antimicrobial investigations
Antimicrobial activity was tested by the disc-diffusion method under standard conditions, using Mueller-Hinton agar medium as described by NCCLS (15) . Each of the investigated isolates of bacteria was seeded in the tubes with nutrient broth (NB), and 1 cm 3 of seeded NB and homogenized was taken in tubes with 9 cm 3 of melted (45°C) nutrient agar (NA). The homogeneous suspension was poured out in Petri dishes. The discs of filter paper (diameter 5 mm) were ranged on cool medium. After cooling on formed solid medium, 2⋅10 -5 dm 3 of the investigated compounds (γ=1000 µg/ml) were placed by micropipette. After incubation for 24 hours in thermostat at 25-27°C, inhibition (sterile) zone diameters (including disc) were measured and expressed in mm. Inhibition zone diameter over 8 mm indicates the tested compound is active against microorganisms under investigation. Every test was done in three replications. In parallel with antimicrobial investigations of the complexes, ligands were tested too.
Minimum inhibitory concentration was determined by the agar dilution method according to guidelines established by the NCCLS standard M7-A5 (16). MIC was descri-bed as the lowest concentration of the compound that visibly inhibited colony`s growth. Stock solutions of the compounds were prepared in dimethylformamide (DMF). Further dilutions were performed with distilled water. The concentration range of the compounds tested was between 60-750 µg/ml in two-fold dilution steps. The inoculated plates were then incubated at 35°C for 16-20 h.
RESULTS AND DISCUSSION
The antimicrobial activity of the 2-aminobenzimidazole derivatives and their cobalt (II) complexes was tested first by the agar disc-diffusion method against gram-positive and gram-negative bacteria and yeast. The results of these studies are summarized in Table 1 . From the data given in Table 1 it is clear that the tested compounds were more active against gram-positive bacteria than against gram-negative Pseudomonas aeruginosa. It may be concluded that the antimicrobial activity of the compounds is related to cell wall structure of the bacteria. 
The results of MIC determination by the agar dilution method are presented in Tables  2-5 . The compounds not shown in the table had no antibacterial activity at the tested concentration.
The results presented in Tables 2-5 indicate that the complex containing cobalt(II) was more active than the starting ligand L 1 against Bacillus sp., Staphylococcus aureus and Sarcina lutea with a MIC value of 250 µg/ml, but less active against Pseudomonas aeruginosa. On the other hand, the cobaltl(II) complex was more active than the starting ligand L 2 , with a MIC value of 250 µg/ml, and equally active as ligand L 3 with a MIC value of 60 µg/ml against Pseudomonas aeruginosa. In the cases of other bacteria the complex was more active than its ligand L 2 , but less active than ligand L 3 . MIC value of [Co(L 2 ) 2 Cl 2 ] was 250 µg/ml, against Bacillus sp. and Sarcina lutea, as wel as 60µg/ml against Staphylococcus aureus. The complex containing L 3 were active against Bacillus sp., Sarcina lutea and Staphylococcus aureus with a MIC value of 250µg/ml, but its ligand was more toxic, with a MIC value of 125 µg/ml, against the same bacteria. Comparing the activities of the tested ligands and their complexes, it was found that if the benzimidazole nucleus was substituted with a 4-methylbenzyl group at the N1 atom, the antimicrobial activity increased (14) . Considering of the structural formula of the compounds that exhibited antimicrobial activity, it can be concluded that substituted ligands and cobalt moiety may play a role in the antimicrobial activity. The antimicrobial potentials of the investigated benzimidazole derivatives are similar to those of different benzimidazoles that were determined in the previous studies (2-4, 10-14 , with a MIC value of 60 µg/ml. MIC value of L 2 complex was 250µg/ml, against Bacillus sp. and Sarcina lutea, and 60 µg/ml against Staphylococcus aureus. The complex containing L 3 was active against Bacillus sp., Sarcina lutea and Staphylococcus aureus, with a MIC value of 250 µg/ml, but its ligand was more toxic, with a MIC value of 125 µg/ml against the same bacteria. Comparing the activities of the tested ligands and their complexes, it was found that if the benzimidazole nucleus was substituted with a 4-methylbenzyl group at the N1 atom, the antimicrobial activity increased. On considering the structural formula of the compounds that exhibited antimicrobial activity, it can be concluded that substituted ligands and cobalt moiety may play a role in the antimicrobial activity. 
